Migraine: Genetic Variants and Clinical Phenotypes

Tfelt-Hansen, P.C.; Koehler, P.J. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache, 2011, 51(5), 752-778.
[http://dx.doi.org/10.1111/j.1526-4610.2011.01892.x] [PMID: 21521208]

Bigal, M.E.; Lipton, R.B. The epidemiology, burden, and comorbidities of migraine. Neurol. Clin., 2009, 27(2), 321-334.
[http://dx.doi.org/10.1016/j.ncl.2008.11.011] [PMID: 19289218]

Vos, T.; Flaxman, A.D.; Naghavi, M.; Lozano, R.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.A.; Abdalla, S.; Aboyans, V.; Abraham, J.; Ackerman, I.; Aggarwal, R.; Ahn, S.Y.; Ali, M.K.; Alvarado, M.; Anderson, H.R.; Anderson, L.M.; Andrews, K.G.; Atkinson, C.; Baddour, L.M.; Bahalim, A.N.; Barker-Collo, S.; Barrero, L.H.; Bartels, D.H.; Basáñez, M.G.; Baxter, A.; Bell, M.L.; Benjamin, E.J.; Bennett, D.; Bernabé, E.; Bhalla, K.; Bhandari, B.; Bikbov, B.; Bin Abdulhak, A.; Birbeck, G.; Black, J.A.; Blencowe, H.; Blore, J.D.; Blyth, F.; Bolliger, I.; Bonaventure, A.; Boufous, S.; Bourne, R.; Boussinesq, M.; Braithwaite, T.; Brayne, C.; Bridgett, L.; Brooker, S.; Brooks, P.; Brugha, T.S.; Bryan-Hancock, C.; Bucello, C.; Buchbinder, R.; Buckle, G.; Budke, C.M.; Burch, M.; Burney, P.; Burstein, R.; Calabria, B.; Campbell, B.; Canter, C.E.; Carabin, H.; Carapetis, J.; Carmona, L.; Cella, C.; Charlson, F.; Chen, H.; Cheng, A.T.; Chou, D.; Chugh, S.S.; Coffeng, L.E.; Colan, S.D.; Colquhoun, S.; Colson, K.E.; Condon, J.; Connor, M.D.; Cooper, L.T.; Corriere, M.; Cortinovis, M.; de Vaccaro, K.C.; Couser, W.; Cowie, B.C.; Criqui, M.H.; Cross, M.; Dabhadkar, K.C.; Dahiya, M.; Dahodwala, N.; Damsere-Derry, J.; Danaei, G.; Davis, A.; De Leo, D.; Degenhardt, L.; Dellavalle, R.; Delossantos, A.; Denenberg, J.; Derrett, S.; Des Jarlais, D.C.; Dharmaratne, S.D.; Dherani, M.; Diaz-Torne, C.; Dolk, H.; Dorsey, E.R.; Driscoll, T.; Duber, H.; Ebel, B.; Edmond, K.; Elbaz, A.; Ali, S.E.; Erskine, H.; Erwin, P.J.; Espindola, P.; Ewoigbokhan, S.E.; Farzadfar, F.; Feigin, V.; Felson, D.T.; Ferrari, A.; Ferri, C.P.; Fèvre, E.M.; Finucane, M.M.; Flaxman, S.; Flood, L.; Foreman, K.; Forouzanfar, M.H.; Fowkes, F.G.; Franklin, R.; Fransen, M.; Freeman, M.K.; Gabbe, B.J.; Gabriel, S.E.; Gakidou, E.; Ganatra, H.A.; Garcia, B.; Gaspari, F.; Gillum, R.F.; Gmel, G.; Gosselin, R.; Grainger, R.; Groeger, J.; Guillemin, F.; Gunnell, D.; Gupta, R.; Haagsma, J.; Hagan, H.; Halasa, Y.A.; Hall, W.; Haring, D.; Haro, J.M.; Harrison, J.E.; Havmoeller, R.; Hay, R.J.; Higashi, H.; Hill, C.; Hoen, B.; Hoffman, H.; Hotez, P.J.; Hoy, D.; Huang, J.J.; Ibeanusi, S.E.; Jacobsen, K.H.; James, S.L.; Jarvis, D.; Jasrasaria, R.; Jayaraman, S.; Johns, N.; Jonas, J.B.; Karthikeyan, G.; Kassebaum, N.; Kawakami, N.; Keren, A.; Khoo, J.P.; King, C.H.; Knowlton, L.M.; Kobusingye, O.; Koranteng, A.; Krishnamurthi, R.; Lalloo, R.; Laslett, L.L.; Lathlean, T.; Leasher, J.L.; Lee, Y.Y.; Leigh, J.; Lim, S.S.; Limb, E.; Lin, J.K.; Lipnick, M.; Lipshultz, S.E.; Liu, W.; Loane, M.; Ohno, S.L.; Lyons, R.; Ma, J.; Mabweijano, J.; MacIntyre, M.F.; Malekzadeh, R.; Mallinger, L.; Manivannan, S.; Marcenes, W.; March, L.; Margolis, D.J.; Marks, G.B.; Marks, R.; Matsumori, A.; Matzopoulos, R.; Mayosi, B.M.; McAnulty, J.H.; McDermott, M.M.; McGill, N.; McGrath, J.; Medina-Mora, M.E.; Meltzer, M.; Mensah, G.A.; Merriman, T.R.; Meyer, A.C.; Miglioli, V.; Miller, M.; Miller, T.R.; Mitchell, P.B.; Mocumbi, A.O.; Moffitt, T.E.; Mokdad, A.A.; Monasta, L.; Montico, M.; Moradi-Lakeh, M.; Moran, A.; Morawska, L.; Mori, R.; Murdoch, M.E.; Mwaniki, M.K.; Naidoo, K.; Nair, M.N.; Naldi, L.; Narayan, K.M.; Nelson, P.K.; Nelson, R.G.; Nevitt, M.C.; Newton, C.R.; Nolte, S.; Norman, P.; Norman, R.; O’Donnell, M.; O’Hanlon, S.; Olives, C.; Omer, S.B.; Ortblad, K.; Osborne, R.; Ozgediz, D.; Page, A.; Pahari, B.; Pandian, J.D.; Rivero, A.P.; Patten, S.B.; Pearce, N.; Padilla, R.P.; Perez-Ruiz, F.; Perico, N.; Pesudovs, K.; Phillips, D.; Phillips, M.R.; Pierce, K.; Pion, S.; Polanczyk, G.V.; Polinder, S.; Pope, C.A., III; Popova, S.; Porrini, E.; Pourmalek, F.; Prince, M.; Pullan, R.L.; Ramaiah, K.D.; Ranganathan, D.; Razavi, H.; Regan, M.; Rehm, J.T.; Rein, D.B.; Remuzzi, G.; Richardson, K.; Rivara, F.P.; Roberts, T.; Robinson, C.; De Leòn, F.R.; Ronfani, L.; Room, R.; Rosenfeld, L.C.; Rushton, L.; Sacco, R.L.; Saha, S.; Sampson, U.; Sanchez-Riera, L.; Sanman, E.; Schwebel, D.C.; Scott, J.G.; Segui-Gomez, M.; Shahraz, S.; Shepard, D.S.; Shin, H.; Shivakoti, R.; Singh, D.; Singh, G.M.; Singh, J.A.; Singleton, J.; Sleet, D.A.; Sliwa, K.; Smith, E.; Smith, J.L.; Stapelberg, N.J.; Steer, A.; Steiner, T.; Stolk, W.A.; Stovner, L.J.; Sudfeld, C.; Syed, S.; Tamburlini, G.; Tavakkoli, M.; Taylor, H.R.; Taylor, J.A.; Taylor, W.J.; Thomas, B.; Thomson, W.M.; Thurston, G.D.; Tleyjeh, I.M.; Tonelli, M.; Towbin, J.A.; Truelsen, T.; Tsilimbaris, M.K.; Ubeda, C.; Undurraga, E.A.; van der Werf, M.J.; van Os, J.; Vavilala, M.S.; Venketasubramanian, N.; Wang, M.; Wang, W.; Watt, K.; Weatherall, D.J.; Weinstock, M.A.; Weintraub, R.; Weisskopf, M.G.; Weissman, M.M.; White, R.A.; Whiteford, H.; Wiersma, S.T.; Wilkinson, J.D.; Williams, H.C.; Williams, S.R.; Witt, E.; Wolfe, F.; Woolf, A.D.; Wulf, S.; Yeh, P.H.; Zaidi, A.K.; Zheng, Z.J.; Zonies, D.; Lopez, A.D.; Murray, C.J.; AlMazroa, M.A.; Memish, Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global burden of disease study 2010. Lancet, 2012, 380(9859), 2163-2196.
[http://dx.doi.org/10.1016/S0140-6736(12)61729-2] [PMID: 23245607]

Steiner, T.J.; Stovner, L.J.; Vos, T. GBD 2015: migraine is the third cause of disability in under 50s. J. Headache Pain, 2016, 17(1), 104.
[http://dx.doi.org/10.1186/s10194-016-0699-5] [PMID: 27844455]

Bonafede, M.; Sapra, S.; Shah, N.; Tepper, S.; Cappell, K.; Desai, P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache, 2018, 58(5), 700-714.
[http://dx.doi.org/10.1111/head.13275] [PMID: 29446063]

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders 3rd edition Cephalalgia,, 2018, 38(1), 1-211.
[http://dx.doi.org/10.1177/0333102417738202] [PMID: 29368949]

Minen, M.T.; Begasse De Dhaem, O.; Kroon Van Diest, A.; Powers, S.; Schwedt, T.J.; Lipton, R.; Silbersweig, D. Migraine and its psychiatric comorbidities. J. Neurol. Neurosurg. Psychiatry, 2016, 87(7), 741-749.
[http://dx.doi.org/10.1136/jnnp-2015-312233] [PMID: 26733600]

Rainero, I.; Govone, F.; Gai, A.; Vacca, A.; Rubino, E. Is Migraine primarily a metaboloendocrine disorder? Curr. Pain Headache Rep., 2018, 22(5), 36.
[http://dx.doi.org/10.1007/s11916-018-0691-7] [PMID: 29619630]

Scher, A.I.; Bigal, M.E.; Lipton, R.B. Comorbidity of migraine. Curr. Opin. Neurol., 2005, 18(3), 305-310.
[http://dx.doi.org/10.1097/01.wco.0000169750.52406.a2] [PMID: 15891417]

Schwedt, T.J. The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol. Clin., 2009, 27(2), 513-523.
[http://dx.doi.org/10.1016/j.ncl.2008.11.006] [PMID: 19289229]

Mulder, E.J.; Van Baal, C.; Gaist, D.; Kallela, M.; Kaprio, J.; Svensson, D.A.; Nyholt, D.R.; Martin, N.G.; MacGregor, A.J.; Cherkas, L.F.; Boomsma, D.I.; Palotie, A. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res., 2003, 6(5), 422-431.
[http://dx.doi.org/10.1375/136905203770326420] [PMID: 14624726]

Svensson, D.A.; Larsson, B.; Waldenlind, E.; Pedersen, N.L. Shared rearing environment in migraine: results from twins reared apart and twins reared together. Headache, 2003, 43(3), 235-244.
[http://dx.doi.org/10.1046/j.1526-4610.2003.03047.x] [PMID: 12603642]

Russell, M.B.; Ulrich, V.; Gervil, M.; Olesen, J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache, 2002, 42(5), 332-336.
[http://dx.doi.org/10.1046/j.1526-4610.2002.02102.x] [PMID: 12047331]

Montagna, P. Migraine genetics. Expert Rev. Neurother., 2008, 8(9), 1321-1330.
[http://dx.doi.org/10.1586/14737175.8.9.1321] [PMID: 18759544]

Tolner, E.A.; Houben, T.; Terwindt, G.M.; de Vries, B.; Ferrari, M.D.; van den Maagdenberg, A.M. From migraine genes to mechanisms. Pain, 2015, 156(Suppl. 1), S64-S74.
[http://dx.doi.org/10.1097/01.j.pain.0000460346.00213.16] [PMID: 25789438]

Pietrobon, D. Familial hemiplegic migraine. Neurotherapeutics, 2007, 4(2), 274-284.
[http://dx.doi.org/10.1016/j.nurt.2007.01.008] [PMID: 17395138]

Liem, M.K.; Oberstein, S.A.; van der Grond, J.; Ferrari, M.D.; Haan, J. CADASIL and migraine: A narrative review. Cephalalgia, 2010, 30(11), 1284-1289.
[http://dx.doi.org/10.1177/0333102410370870] [PMID: 21038489]

Xu, Y.; Padiath, Q.S.; Shapiro, R.E.; Jones, C.R.; Wu, S.C.; Saigoh, N.; Saigoh, K.; Ptácek, L.J.; Fu, Y.H. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature, 2005, 434(7033), 640-644.
[http://dx.doi.org/10.1038/nature03453] [PMID: 15800623]

Stam, A.H.; Kothari, P.H.; Shaikh, A.; Gschwendter, A.; Jen, J.C.; Hodgkinson, S.; Hardy, T.A.; Hayes, M.; Kempster, P.A.; Kotschet, K.E.; Bajema, I.M.; van Duinen, S.G.; Maat-Schieman, M.L.C.; de Jong, P.T.V.M.; de Smet, M.D.; de Wolff-Rouendaal, D.; Dijkman, G.; Pelzer, N.; Kolar, G.R.; Schmidt, R.E.; Lacey, J.; Joseph, D.; Fintak, D.R.; Grand, M.G.; Brunt, E.M.; Liapis, H.; Hajj-Ali, R.A.; Kruit, M.C.; van Buchem, M.A.; Dichgans, M.; Frants, R.R.; van den Maagdenberg, A.M.J.M.; Haan, J.; Baloh, R.W.; Atkinson, J.P.; Terwindt, G.M.; Ferrari, M.D. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain, 2016, 139(11), 2909-2922.
[http://dx.doi.org/10.1093/brain/aww217] [PMID: 27604306]

Kowalska, M.; Prendecki, M.; Kozubski, W.; Lianeri, M.; Dorszewska, J. Molecular factors in migraine. Oncotarget, 2016, 7(31), 50708-50718.
[http://dx.doi.org/10.18632/oncotarget.9367] [PMID: 27191890]

Anttila, V.; Wessman, M.; Kallela, M.; Palotie, A. Genetics of migraine. Handb. Clin. Neurol., 2018, 148, 493-503.
[http://dx.doi.org/10.1016/B978-0-444-64076-5.00031-4] [PMID: 29478595]

Ophoff, R.A.; Terwindt, G.M.; Vergouwe, M.N.; van Eijk, R.; Oefner, P.J.; Hoffman, S.M.; Lamerdin, J.E.; Mohrenweiser, H.W.; Bulman, D.E.; Ferrari, M.; Haan, J.; Lindhout, D.; van Ommen, G.J.; Hofker, M.H.; Ferrari, M.D.; Frants, R.R. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca²⁺ channel gene CACNL1A4. Cell, 1996, 87(3), 543-552.
[http://dx.doi.org/10.1016/S0092-8674(00)81373-2] [PMID: 8898206]

De Fusco, M.; Marconi, R.; Silvestri, L.; Atorino, L.; Rampoldi, L.; Morgante, L.; Ballabio, A.; Aridon, P.; Casari, G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet., 2003, 33(2), 192-196.
[http://dx.doi.org/10.1038/ng1081] [PMID: 12539047]

Dichgans, M.; Freilinger, T.; Eckstein, G.; Babini, E.; Lorenz-Depiereux, B.; Biskup, S.; Ferrari, M.D.; Herzog, J.; van den Maagdenberg, A.M.; Pusch, M.; Strom, T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet, 2005, 366(9483), 371-377.
[http://dx.doi.org/10.1016/S0140-6736(05)66786-4] [PMID: 16054936]

Hiekkala, M.E.; Vuola, P.; Artto, V.; Häppölä, P.; Häppölä, E.; Vepsäläinen, S.; Cuenca-León, E.; Lal, D.; Gormley, P.; Hämäläinen, E.; Ilmavirta, M.; Nissilä, M.; Säkö, E.; Sumelahti, M.L.; Harno, H.; Havanka, H.; Keski-Säntti, P.; Färkkilä, M.; Palotie, A.; Wessman, M.; Kaunisto, M.A.; Kallela, M. The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families. Cephalalgia, 2018, 38(12), 1849-1863.
[http://dx.doi.org/10.1177/0333102418761041] [PMID: 29486580]

Lafrenière, R.G.; Cader, M.Z.; Poulin, J.F.; Andres-Enguix, I.; Simoneau, M.; Gupta, N.; Boisvert, K.; Lafrenière, F.; McLaughlan, S.; Dubé, M.P.; Marcinkiewicz, M.M.; Ramagopalan, S.; Ansorge, O.; Brais, B.; Sequeiros, J.; Pereira-Monteiro, J.M.; Griffiths, L.R.; Tucker, S.J.; Ebers, G.; Rouleau, G.A. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat. Med., 2010, 16(10), 1157-1160.
[http://dx.doi.org/10.1038/nm.2216] [PMID: 20871611]

Menon, S.; Cox, H.C.; Kuwahata, M.; Quinlan, S.; MacMillan, J.C.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Association of a Notch 3 gene polymorphism with migraine susceptibility. Cephalalgia, 2011, 31(3), 264-270.
[http://dx.doi.org/10.1177/0333102410381143] [PMID: 20813781]

Sheerin, U.M.; Stamelou, M.; Charlesworth, G.; Shiner, T.; Spacey, S.; Valente, E.M.; Wood, N.W.; Bhatia, K.P. Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation. J. Neurol., 2013, 260(2), 656-660.
[http://dx.doi.org/10.1007/s00415-012-6747-4] [PMID: 23180180]

Richards, A.; van den Maagdenberg, A.M.; Jen, J.C.; Kavanagh, D.; Bertram, P.; Spitzer, D.; Liszewski, M.K.; Barilla-Labarca, M.L.; Terwindt, G.M.; Kasai, Y.; McLellan, M.; Grand, M.G.; Vanmolkot, K.R.; de Vries, B.; Wan, J.; Kane, M.J.; Mamsa, H.; Schäfer, R.; Stam, A.H.; Haan, J.; de Jong, P.T.; Storimans, C.W.; van Schooneveld, M.J.; Oosterhuis, J.A.; Gschwendter, A.; Dichgans, M.; Kotschet, K.E.; Hodgkinson, S.; Hardy, T.A.; Delatycki, M.B.; Hajj-Ali, R.A.; Kothari, P.H.; Nelson, S.F.; Frants, R.R.; Baloh, R.W.; Ferrari, M.D.; Atkinson, J.P. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet., 2007, 39(9), 1068-1070.
[http://dx.doi.org/10.1038/ng2082] [PMID: 17660820]

Nagata, E.; Fujii, N.; Hosomichi, K.; Mitsunaga, S.; Suzuki, Y.; Mashimo, Y.; Tsukamoto, H.; Satoh, T.; Osawa, M.; Inoue, I.; Hata, A.; Takizawa, S. Possible association between dysfunction of vitamin D binding protein (GC Globulin) and migraine attacks. PLoS One, 2014, 9(8)e105319
[http://dx.doi.org/10.1371/journal.pone.0105319] [PMID: 25147936]

Suzuki, M.; Van Paesschen, W.; Stalmans, I.; Horita, S.; Yamada, H.; Bergmans, B.A.; Legius, E.; Riant, F.; De Jonghe, P.; Li, Y.; Sekine, T.; Igarashi, T.; Fujimoto, I.; Mikoshiba, K.; Shimadzu, M.; Shiohara, M.; Braverman, N.; Al-Gazali, L.; Fujita, T.; Seki, G. Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc. Natl. Acad. Sci. USA, 2010, 107(36), 15963-15968.
[http://dx.doi.org/10.1073/pnas.1008705107] [PMID: 20798035]

Kondratieva, N.; Azimova, J.; Skorobogatykh, K.; Sergeev, A.; Naumova, E.; Kokaeva, Z.; Anuchina, A.; Rudko, O.; Tabeeva, G.; Klimov, E. Biomarkers of migraine: Part 1 - genetic markers. J. Neurol. Sci., 2016, 369, 63-76.
[http://dx.doi.org/10.1016/j.jns.2016.08.008] [PMID: 27653868]

Gasparini, C.F.; Sutherland, H.G.; Griffiths, L.R. Studies on the pathophysiology and genetic basis of migraine. Curr. Genomics, 2013, 14(5), 300-315.
[http://dx.doi.org/10.2174/13892029113149990007] [PMID: 24403849]

De Marchis, M.L.; Barbanti, P.; Palmirotta, R.; Egeo, G.; Aurilia, C.; Fofi, L.; Piroso, S.; Ialongo, C.; Della-Morte, D.; D’Andrea, G.; Ferroni, P.; Guadagni, F. Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study. J. Headache Pain, 2015, 16, 520.
[http://dx.doi.org/10.1186/s10194-015-0520-x] [PMID: 25929431]

Rainero, I.; Rubino, E.; Paemeleire, K.; Gai, A.; Vacca, A.; De Martino, P.; Gentile, S.; Sarchielli, P.; Pinessi, L. Genes and primary headaches: discovering new potential therapeutic targets. J. Headache Pain, 2013, 14, 61.
[http://dx.doi.org/10.1186/1129-2377-14-61] [PMID: 23848401]

Schürks, M.; Rist, P.M.; Kurth, T. Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia, 2010, 30(11), 1306-1328.
[http://dx.doi.org/10.1177/0333102410364155] [PMID: 20959426]

Gormley, P.; Anttila, V.; Winsvold, B.S.; Palta, P.; Esko, T.; Pers, T.H.; Farh, K.H.; Cuenca-Leon, E.; Muona, M.; Furlotte, N.A.; Kurth, T.; Ingason, A.; McMahon, G.; Ligthart, L.; Terwindt, G.M.; Kallela, M.; Freilinger, T.M.; Ran, C.; Gordon, S.G.; Stam, A.H.; Steinberg, S.; Borck, G.; Koiranen, M.; Quaye, L.; Adams, H.H.; Lehtimäki, T.; Sarin, A.P.; Wedenoja, J.; Hinds, D.A.; Buring, J.E.; Schürks, M.; Ridker, P.M.; Hrafnsdottir, M.G.; Stefansson, H.; Ring, S.M.; Hottenga, J.J.; Penninx, B.W.; Färkkilä, M.; Artto, V.; Kaunisto, M.; Vepsäläinen, S.; Malik, R.; Heath, A.C.; Madden, P.A.; Martin, N.G.; Montgomery, G.W.; Kurki, M.I.; Kals, M.; Mägi, R.; Pärn, K.; Hämäläinen, E.; Huang, H.; Byrnes, A.E.; Franke, L.; Huang, J.; Stergiakouli, E.; Lee, P.H.; Sandor, C.; Webber, C.; Cader, Z.; Muller-Myhsok, B.; Schreiber, S.; Meitinger, T.; Eriksson, J.G.; Salomaa, V.; Heikkilä, K.; Loehrer, E.; Uitterlinden, A.G.; Hofman, A.; van Duijn, C.M.; Cherkas, L.; Pedersen, L.M.; Stubhaug, A.; Nielsen, C.S.; Männikkö, M.; Mihailov, E.; Milani, L.; Göbel, H.; Esserlind, A.L.; Christensen, A.F.; Hansen, T.F.; Werge, T.; Kaprio, J.; Aromaa, A.J.; Raitakari, O.; Ikram, M.A.; Spector, T.; Järvelin, M.R.; Metspalu, A.; Kubisch, C.; Strachan, D.P.; Ferrari, M.D.; Belin, A.C.; Dichgans, M.; Wessman, M.; van den Maagdenberg, A.M.; Zwart, J.A.; Boomsma, D.I.; Smith, G.D.; Stefansson, K.; Eriksson, N.; Daly, M.J.; Neale, B.M.; Olesen, J.; Chasman, D.I.; Nyholt, D.R.; Palotie, A. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet., 2016, 48(8), 856-866.
[http://dx.doi.org/10.1038/ng.3598] [PMID: 27322543]

Chasman, D.I.; Schürks, M.; Anttila, V.; de Vries, B.; Schminke, U.; Launer, L.J.; Terwindt, G.M.; van den Maagdenberg, A.M.; Fendrich, K.; Völzke, H.; Ernst, F.; Griffiths, L.R.; Buring, J.E.; Kallela, M.; Freilinger, T.; Kubisch, C.; Ridker, P.M.; Palotie, A.; Ferrari, M.D.; Hoffmann, W.; Zee, R.Y.; Kurth, T. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet., 2011, 43(7), 695-698.
[http://dx.doi.org/10.1038/ng.856] [PMID: 21666692]

Anttila, V.; Winsvold, B.S.; Gormley, P.; Kurth, T.; Bettella, F.; McMahon, G.; Kallela, M.; Malik, R.; de Vries, B.; Terwindt, G.; Medland, S.E.; Todt, U.; McArdle, W.L.; Quaye, L.; Koiranen, M.; Ikram, M.A.; Lehtimäki, T.; Stam, A.H.; Ligthart, L.; Wedenoja, J.; Dunham, I.; Neale, B.M.; Palta, P.; Hamalainen, E.; Schürks, M.; Rose, L.M.; Buring, J.E.; Ridker, P.M.; Steinberg, S.; Stefansson, H.; Jakobsson, F.; Lawlor, D.A.; Evans, D.M.; Ring, S.M.; Färkkilä, M.; Artto, V.; Kaunisto, M.A.; Freilinger, T.; Schoenen, J.; Frants, R.R.; Pelzer, N.; Weller, C.M.; Zielman, R.; Heath, A.C.; Madden, P.A.F.; Montgomery, G.W.; Martin, N.G.; Borck, G.; Göbel, H.; Heinze, A.; Heinze-Kuhn, K.; Williams, F.M.K.; Hartikainen, A.L.; Pouta, A.; van den Ende, J.; Uitterlinden, A.G.; Hofman, A.; Amin, N.; Hottenga, J.J.; Vink, J.M.; Heikkilä, K.; Alexander, M.; Muller-Myhsok, B.; Schreiber, S.; Meitinger, T.; Wichmann, H.E.; Aromaa, A.; Eriksson, J.G.; Traynor, B.; Trabzuni, D.; Rossin, E.; Lage, K.; Jacobs, S.B.R.; Gibbs, J.R.; Birney, E.; Kaprio, J.; Penninx, B.W.; Boomsma, D.I.; van Duijn, C.; Raitakari, O.; Jarvelin, M.R.; Zwart, J.A.; Cherkas, L.; Strachan, D.P.; Kubisch, C.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Dichgans, M.; Wessman, M.; Smith, G.D.; Stefansson, K.; Daly, M.J.; Nyholt, D.R.; Chasman, D.; Palotie, A. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet., 2013, 45(8), 912-917.
[http://dx.doi.org/10.1038/ng.2676] [PMID: 23793025]

Freilinger, T.; Anttila, V.; de Vries, B.; Malik, R.; Kallela, M.; Terwindt, G.M.; Pozo-Rosich, P.; Winsvold, B.; Nyholt, D.R.; van Oosterhout, W.P.; Artto, V.; Todt, U.; Hämäläinen, E.; Fernández-Morales, J.; Louter, M.A.; Kaunisto, M.A.; Schoenen, J.; Raitakari, O.; Lehtimäki, T.; Vila-Pueyo, M.; Göbel, H.; Wichmann, E.; Sintas, C.; Uitterlinden, A.G.; Hofman, A.; Rivadeneira, F.; Heinze, A.; Tronvik, E.; van Duijn, C.M.; Kaprio, J.; Cormand, B.; Wessman, M.; Frants, R.R.; Meitinger, T.; Müller-Myhsok, B.; Zwart, J.A.; Färkkilä, M.; Macaya, A.; Ferrari, M.D.; Kubisch, C.; Palotie, A.; Dichgans, M.; van den Maagdenberg, A.M. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet., 2012, 44(7), 777-782.
[http://dx.doi.org/10.1038/ng.2307] [PMID: 22683712]

Anttila, V.; Stefansson, H.; Kallela, M.; Todt, U.; Terwindt, G.M.; Calafato, M.S.; Nyholt, D.R.; Dimas, A.S.; Freilinger, T.; Müller-Myhsok, B.; Artto, V.; Inouye, M.; Alakurtti, K.; Kaunisto, M.A.; Hämäläinen, E.; de Vries, B.; Stam, A.H.; Weller, C.M.; Heinze, A.; Heinze-Kuhn, K.; Goebel, I.; Borck, G.; Göbel, H.; Steinberg, S.; Wolf, C.; Björnsson, A.; Gudmundsson, G.; Kirchmann, M.; Hauge, A.; Werge, T.; Schoenen, J.; Eriksson, J.G.; Hagen, K.; Stovner, L.; Wichmann, H.E.; Meitinger, T.; Alexander, M.; Moebus, S.; Schreiber, S.; Aulchenko, Y.S.; Breteler, M.M.; Uitterlinden, A.G.; Hofman, A.; van Duijn, C.M.; Tikka-Kleemola, P.; Vepsäläinen, S.; Lucae, S.; Tozzi, F.; Muglia, P.; Barrett, J.; Kaprio, J.; Färkkilä, M.; Peltonen, L.; Stefansson, K.; Zwart, J.A.; Ferrari, M.D.; Olesen, J.; Daly, M.; Wessman, M.; van den Maagdenberg, A.M.; Dichgans, M.; Kubisch, C.; Dermitzakis, E.T.; Frants, R.R.; Palotie, A. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet., 2010, 42(10), 869-873.
[http://dx.doi.org/10.1038/ng.652] [PMID: 20802479]

Cox, H.C.; Lea, R.A.; Bellis, C.; Carless, M.; Dyer, T.D.; Curran, J.; Charlesworth, J.; Macgregor, S.; Nyholt, D.; Chasman, D.; Ridker, P.M.; Schürks, M.; Blangero, J.; Griffiths, L.R. A genome-wide analysis of ‘Bounty’ descendants implicates several novel variants in migraine susceptibility. Neurogenetics, 2012, 13(3), 261-266.
[http://dx.doi.org/10.1007/s10048-012-0325-x] [PMID: 22678113]

Pellacani, S.; Sicca, F.; Di Lorenzo, C.; Grieco, G.S.; Valvo, G.; Cereda, C.; Rubegni, A.; Santorelli, F.M. The Revolution in migraine genetics: from aching channels disorders to a next-generation medicine. Front. Cell. Neurosci., 2016, 10, 156.
[http://dx.doi.org/10.3389/fncel.2016.00156] [PMID: 27378853]

Esserlind, A.L.; Christensen, A.F.; Steinberg, S.; Grarup, N.; Pedersen, O.; Hansen, T.; Werge, T.; Hansen, T.F.; Husemoen, L.L.; Linneberg, A.; Budtz-Jorgensen, E.; Westergaard, M.L.; Stefansson, H.; Olesen, J. The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample. Cephalalgia, 2016, 36(7), 615-623.
[http://dx.doi.org/10.1177/0333102415570492] [PMID: 25667298]

Chasman, D.I.; Anttila, V.; Buring, J.E.; Ridker, P.M.; Schürks, M.; Kurth, T. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet., 2014, 10(5)e1004366
[http://dx.doi.org/10.1371/journal.pgen.1004366] [PMID: 24852292]

Russell, M.B.; Ducros, A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol., 2011, 10(5), 457-470.
[http://dx.doi.org/10.1016/S1474-4422(11)70048-5] [PMID: 21458376]

Tottene, A.; Fellin, T.; Pagnutti, S.; Luvisetto, S.; Striessnig, J.; Fletcher, C.; Pietrobon, D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. USA, 2002, 99(20), 13284-13289.
[http://dx.doi.org/10.1073/pnas.192242399] [PMID: 12235360]

Pietrobon, D. Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J. Physiol., 2010, 588(Pt 11), 1871-1878.
[http://dx.doi.org/10.1113/jphysiol.2010.188003] [PMID: 20194127]

Plomp, J.J.; van den Maagdenberg, A.M.; Molenaar, P.C.; Frants, R.R.; Ferrari, M.D. Mutant P/Q-type calcium channel electrophysiology and migraine. Curr. Opin. Investig. Drugs, 2001, 2(9), 1250-1260.
[PMID: 11717812]

Kirchmann, M.; Thomsen, L.L.; Olesen, J. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2006, 141B(3), 250-256.
[http://dx.doi.org/10.1002/ajmg.b.30277] [PMID: 16508934]

Noble-Topham, S.E.; Dyment, D.A.; Cader, M.Z.; Ganapathy, R.; Brown, J.D.; Rice, G.P.; Ebers, G.C. Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology, 2002, 59(7), 1099-1101.
[http://dx.doi.org/10.1212/WNL.59.7.1099] [PMID: 12370474]

Barros, J.; Damásio, J.; Tuna, A.; Alves, I.; Silveira, I.; Pereira-Monteiro, J.; Sequeiros, J.; Alonso, I.; Sousa, A.; Coutinho, P. Cerebellar ataxia, hemiplegic migraine, and related phenotypes due to a CACNA1A missense mutation: 12-year follow-up of a large Portuguese family. JAMA Neurol., 2013, 70(2), 235-240.
[http://dx.doi.org/10.1001/jamaneurol.2013.591] [PMID: 23407676]

Lebas, A.; Guyant-Marechal, L.; Hannequin, D.; Riant, F.; Tournier-Lasserve, E.; Parain, D. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia, 2008, 28(7), 774-777.
[http://dx.doi.org/10.1111/j.1468-2982.2008.01603.x]

Pelzer, N.; Haan, J.; Stam, A.H.; Vijfhuizen, L.S.; Koelewijn, S.C.; Smagge, A.; de Vries, B.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Terwindt, G.M. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology, 2018, 90(7), e575-e582.
[http://dx.doi.org/10.1212/WNL.0000000000004966] [PMID: 29343472]

Friedrich, T.; Tavraz, N.N.; Junghans, C. ATP1A2 Mutations in migraine: seeing through the facets of an ion pump onto the neurobiology of disease. Front. Physiol., 2016, 7, 239.
[http://dx.doi.org/10.3389/fphys.2016.00239] [PMID: 27445835]

Prontera, P.; Sarchielli, P.; Caproni, S.; Bedetti, C.; Cupini, L.M.; Calabresi, P.; Costa, C. Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications. Cephalalgia, 2018, 38(2), 361-373.
[http://dx.doi.org/10.1177/0333102416686347] [PMID: 28058944]

Harkin, L.A.; McMahon, J.M.; Iona, X.; Dibbens, L.; Pelekanos, J.T.; Zuberi, S.M.; Sadleir, L.G.; Andermann, E.; Gill, D.; Farrell, K.; Connolly, M.; Stanley, T.; Harbord, M.; Andermann, F.; Wang, J.; Batish, S.D.; Jones, J.G.; Seltzer, W.K.; Gardner, A.; Sutherland, G.; Berkovic, S.F.; Mulley, J.C.; Scheffer, I.E.; Scheffer, I.E. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain, 2007, 130(Pt 3), 843-852.
[http://dx.doi.org/10.1093/brain/awm002] [PMID: 17347258]

Verbeek, N.E.; van Kempen, M.; Gunning, W.B.; Renier, W.O.; Westland, B.; Lindhout, D.; Brilstra, E.H. Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A gene. Epilepsia, 2011, 52(4), e23-e25.
[http://dx.doi.org/10.1111/j.1528-1167.2011.02982.x] [PMID: 21371021]

Fan, C.; Wolking, S.; Lehmann-Horn, F.; Hedrich, U.B.; Freilinger, T.; Lerche, H.; Borck, G.; Kubisch, C.; Jurkat-Rott, K. Early-onset familial hemiplegic migraine due to a novel SCN1A mutation. Cephalalgia, 2016, 36(13), 1238-1247.
[http://dx.doi.org/10.1177/0333102415608360] [PMID: 26763045]

Weller, C.M.; Pelzer, N.; de Vries, B.; López, M.A.; De Fàbregues, O.; Pascual, J.; Arroyo, M.A.; Koelewijn, S.C.; Stam, A.H.; Haan, J.; Ferrari, M.D.; Terwindt, G.M.; van den Maagdenberg, A.M. Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia, 2014, 34(13), 1062-1069.
[http://dx.doi.org/10.1177/0333102414529195] [PMID: 24707016]

Callejo, G.; Giblin, J.P.; Gasull, X. Modulation of TRESK background K⁺ channel by membrane stretch. PLoS One, 2013, 8(5)e64471
[http://dx.doi.org/10.1371/journal.pone.0064471] [PMID: 23691227]

Dobler, T.; Springauf, A.; Tovornik, S.; Weber, M.; Schmitt, A.; Sedlmeier, R.; Wischmeyer, E.; Döring, F. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J. Physiol., 2007, 585(Pt 3), 867-879.
[http://dx.doi.org/10.1113/jphysiol.2007.145649] [PMID: 17962323]

Andres-Enguix, I.; Shang, L.; Stansfeld, P.J.; Morahan, J.M.; Sansom, M.S.; Lafrenière, R.G.; Roy, B.; Griffiths, L.R.; Rouleau, G.A.; Ebers, G.C.; Cader, Z.M.; Tucker, S.J. Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci. Rep., 2012, 2, 237.
[http://dx.doi.org/10.1038/srep00237] [PMID: 22355750]

Rainero, I.; Rubino, E.; Gallone, S.; Zavarise, P.; Carli, D.; Boschi, S.; Fenoglio, P.; Savi, L.; Gentile, S.; Benna, P.; Pinessi, L.; Dalla Volta, G. KCNK18 (TRESK) genetic variants in Italian patients with migraine. Headache, 2014, 54(9), 1515-1522.
[http://dx.doi.org/10.1111/head.12439] [PMID: 25324165]

Joutel, A.; Corpechot, C.; Ducros, A.; Vahedi, K.; Chabriat, H.; Mouton, P.; Alamowitch, S.; Domenga, V.; Cécillion, M.; Marechal, E.; Maciazek, J.; Vayssiere, C.; Cruaud, C.; Cabanis, E.A.; Ruchoux, M.M.; Weissenbach, J.; Bach, J.F.; Bousser, M.G.; Tournier-Lasserve, E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 1996, 383(6602), 707-710.
[http://dx.doi.org/10.1038/383707a0] [PMID: 8878478]

Monet-Leprêtre, M.; Bardot, B.; Lemaire, B.; Domenga, V.; Godin, O.; Dichgans, M.; Tournier-Lasserve, E.; Cohen-Tannoudji, M.; Chabriat, H.; Joutel, A. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain, 2009, 132(Pt 6), 1601-1612.
[http://dx.doi.org/10.1093/brain/awp049] [PMID: 19293235]

Meng, H.; Zhang, X.; Yu, G.; Lee, S.J.; Chen, Y.E.; Prudovsky, I.; Wang, M.M. Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3. PLoS One, 2012, 7(9)e44964
[http://dx.doi.org/10.1371/journal.pone.0044964] [PMID: 23028706]

Di Donato, I.; Bianchi, S.; De Stefano, N.; Dichgans, M.; Dotti, M.T.; Duering, M.; Jouvent, E.; Korczyn, A.D.; Lesnik-Oberstein, S.A.; Malandrini, A.; Markus, H.S.; Pantoni, L.; Penco, S.; Rufa, A.; Sinanović, O.; Stojanov, D.; Federico, A. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med., 2017, 15(1), 41.
[http://dx.doi.org/10.1186/s12916-017-0778-8] [PMID: 28231783]

Rubino, E.; Fenoglio, P.; Gallone, S.; Govone, F.; Vacca, A.; De Martino, P.; Giobbe, M.L.; Boschi, S.; Pinessi, L.; Gentile, S.; Rainero, I. Genetic variants in the NOTCH4 gene influence the clinical features of migraine. J. Headache Pain, 2013, 14, 28.
[http://dx.doi.org/10.1186/1129-2377-14-28] [PMID: 23566281]

Rossi, P.; Sterlini, B.; Castroflorio, E.; Marte, A.; Onofri, F.; Valtorta, F.; Maragliano, L.; Corradi, A.; Benfenati, F. A novel topology of Proline-rich Transmembrane Protein 2 (PRRT2): HINTS FOR AN INTRACELLULAR FUNCTION AT THE SYNAPSE. J. Biol. Chem., 2016, 291(12), 6111-6123.
[http://dx.doi.org/10.1074/jbc.M115.683888] [PMID: 26797119]

Pelzer, N.; de Vries, B.; Kamphorst, J.T.; Vijfhuizen, L.S.; Ferrari, M.D.; Haan, J.; van den Maagdenberg, A.M.; Terwindt, G.M. PRRT2 and hemiplegic migraine: a complex association. Neurology, 2014, 83(3), 288-290.
[http://dx.doi.org/10.1212/WNL.0000000000000590] [PMID: 24928127]

Cevoli, S.; Giannini, G.; Favoni, V.; Pierangeli, G.; Cortelli, P. Migraine and sleep disorders. Neurol. Sci., 2012, 33(Suppl. 1), S43-S46.
[http://dx.doi.org/10.1007/s10072-012-1030-0] [PMID: 22644169]

McCully, K.S. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann. Clin. Lab. Sci., 2009, 39(3), 219-232.
[PMID: 19667406]

Dionisio, N.; Jardín, I.; Salido, G.M.; Rosado, J.A. Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem., 2010, 17(27), 3109-3119.
[http://dx.doi.org/10.2174/092986710791959783] [PMID: 20629621]

Zieminska, E.; Lazarewicz, J.W. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol. Exp. (Warsz.), 2006, 66(4), 301-309.
[PMID: 17265692]

Yeganeh, F.; Nikbakht, F.; Bahmanpour, S.; Rastegar, K.; Namavar, R. Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. J. Mol. Neurosci., 2013, 50(3), 551-557.
[http://dx.doi.org/10.1007/s12031-013-9996-5] [PMID: 23564299]

Frosst, P.; Blom, H.J.; Milos, R.; Goyette, P.; Sheppard, C.A.; Matthews, R.G.; Boers, G.J.; den Heijer, M.; Kluijtmans, L.A.; van den Heuvel, L.P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 1995, 10(1), 111-113.
[http://dx.doi.org/10.1038/ng0595-111] [PMID: 7647779]

Samaan, Z.; Gaysina, D.; Cohen-Woods, S.; Craddock, N.; Jones, L.; Korszun, A.; Owen, M.; Mente, A.; McGuffin, P.; Farmer, A. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol., 2011, 11, 66.
[http://dx.doi.org/10.1186/1471-2377-11-66] [PMID: 21635773]

Liu, A.; Menon, S.; Colson, N.J.; Quinlan, S.; Cox, H.; Peterson, M.; Tiang, T.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res. Notes, 2010, 3, 213.
[http://dx.doi.org/10.1186/1756-0500-3-213] [PMID: 20663228]

Liu, R.; Geng, P.; Ma, M.; Yu, S.; Yang, M.; He, M.; Dong, Z.; Zhang, W. MTHFR C677T polymorphism and migraine risk: a meta-analysis. J. Neurol. Sci., 2014, 336(1-2), 68-73.
[http://dx.doi.org/10.1016/j.jns.2013.10.008] [PMID: 24183284]

Schürks, M.; Rist, P.M.; Kurth, T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache, 2010, 50(4), 588-599.
[http://dx.doi.org/10.1111/j.1526-4610.2009.01570.x] [PMID: 19925624]

Rubino, E.; Ferrero, M.; Rainero, I.; Binello, E.; Vaula, G.; Pinessi, L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia, 2009, 29(8), 818-825.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01400.x] [PMID: 17714520]

Azimova, J.E.; Sergeev, A.V.; Korobeynikova, L.A.; Kondratieva, N.S.; Kokaeva, Z.G.; Shaikhaev, G.O.; Skorobogatykh, K.V.; Fokina, N.M.; Tabeeva, G.R.; Klimov, E.A. Effects of MTHFR gene polymorphism on the clinical and electrophysiological characteristics of migraine. BMC Neurol., 2013, 13, 103.
[http://dx.doi.org/10.1186/1471-2377-13-103] [PMID: 23915182]

Bahadir, A.; Eroz, R.; Dikici, S. Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue. Cell. Mol. Neurobiol., 2013, 33(8), 1055-1063.
[http://dx.doi.org/10.1007/s10571-013-9972-1] [PMID: 23975093]

Magis, D.; Allena, M.; Coppola, G.; Di Clemente, L.; Gérard, P.; Schoenen, J. Search for correlations between genotypes and electrophysiological patterns in migraine: the MTHFR C677T polymorphism and visual evoked potentials. Cephalalgia, 2007, 27(10), 1142-1149.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01412.x] [PMID: 17711493]

de Tommaso, M.; Difruscolo, O.; Sardaro, M.; Losito, L.; Serpino, C.; Pietrapertosa, A.; Santeramo, M.T.; Dicuonzo, F.; Carella, A.; Lamberti, P.; Livrea, P. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache, 2007, 47(2), 253-265.
[http://dx.doi.org/10.1111/j.1526-4610.2006.00690.x] [PMID: 17300365]

Lea, R.; Colson, N.; Quinlan, S.; Macmillan, J.; Griffiths, L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet. Genomics, 2009, 19(6), 422-428.
[http://dx.doi.org/10.1097/FPC.0b013e32832af5a3] [PMID: 19384265]

Lesch, K.P.; Bengel, D.; Heils, A.; Sabol, S.Z.; Greenberg, B.D.; Petri, S.; Benjamin, J.; Müller, C.R.; Hamer, D.H.; Murphy, D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 1996, 274(5292), 1527-1531.
[http://dx.doi.org/10.1126/science.274.5292.1527] [PMID: 8929413]

Chang, C.C.; Chang, H.A.; Fang, W.H.; Chang, T.C.; Huang, S.Y. Gender-specific association between serotonin transporter polymorphisms (5-HTTLPR and rs25531) and neuroticism, anxiety and depression in well-defined healthy Han Chinese. J. Affect. Disord., 2017, 207, 422-428.
[http://dx.doi.org/10.1016/j.jad.2016.08.055] [PMID: 27788383]

Schürks, M.; Rist, P.M.; Kurth, T. 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis. Cephalalgia, 2010, 30(11), 1296-1305.
[http://dx.doi.org/10.1177/0333102410362929] [PMID: 20959425]

Kraya, T.; Deschauer, M.; Joshi, P.R.; Zierz, S.; Gaul, C. Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study. Headache, 2018, 58(1), 45-52.
[http://dx.doi.org/10.1111/head.13219] [PMID: 29139113]

Yorns, W.R., Jr; Hardison, H.H. Mitochondrial dysfunction in migraine. Semin. Pediatr. Neurol., 2013, 20(3), 188-193.
[http://dx.doi.org/10.1016/j.spen.2013.09.002] [PMID: 24331360]

Vollono, C.; Primiano, G.; Della Marca, G.; Losurdo, A.; Servidei, S. Migraine in mitochondrial disorders: Prevalence and characteristics. Cephalalgia, 2018, 38(6), 1093-1106.
[http://dx.doi.org/10.1177/0333102417723568] [PMID: 28762753]

Stuart, S.; Benton, M.C.; Eccles, D.A.; Sutherland, H.G.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Gene-centric analysis implicates nuclear encoded mitochondrial protein gene variants in migraine susceptibility. Mol. Genet. Genomic Med., 2017, 5(2), 157-163.
[http://dx.doi.org/10.1002/mgg3.270]